ACE Inhibitors and AT1R Blockers for COVID-2019: Friends or Foes ?

Daniele Focosi; Marco Tuccori; Fabrizio Maggi

doi:10.20944/preprints202004.0151.v2

Preprint Hypothesis Version 2 Preserved in Portico This version is not peer-reviewed

Version 1 : Received: 8 April 2020 / Approved: 9 April 2020 / Online: 9 April 2020 (12:34:46 CEST)
Version 2 : Received: 21 April 2020 / Approved: 22 April 2020 / Online: 22 April 2020 (09:46:54 CEST)

Human respiratory beta coronavirus are emerging causes for Public Health Emergencies of International Concern (PHEIC). SARS-CoV2 is circulating worldwide since November 2019. We review here the cardiovascular morbidity and mortality in COVID-19, and data supporting the role for dysregulation of the RAS counterregulatory axis due to binding of SARS-CoV2 S protein to ACE2 receptor. Since this counterregulatory axis provides benefits not only on the cardiovascular front but also in acute lung injury, we speculate on potential use of ACE inhibitors and AT₁R blockers in critically ill COVID-19 patients, and report current evidences.

COVID-19; ACEI; ARB; SARS; ALI; ARDS

Biology and Life Sciences, Virology

Comment 1

Received: 22 April 2020
Commenter: Daniele Focosi
Commenter's Conflict of Interests: Author

Comment: Added more references from published trials.

+ Respond to this comment

Not displayed online.

Please leave your comment to this article below.

Mathematical equations can be typed in either LaTeX formats \\[ ... \\] or $$ ... $$, or MathML format <math> ... </math>. Try the LaTeX or MathML example.

Type equation:

Preview:

Copy equation into message below

Close menu

Please click a symbol to insert it into the message box below:

Please enter the link here:

Optionally, you can enter text that should appear as linked text:

Copy link into message below

Close menu

Please enter or paste the URL to the image here (please only use links to jpg/jpeg, png and gif images):

Copy image into message below

Close menu

Type author name or keywords to filter the list of references in this group (you can add a new citation under Bibliography):

No existing citations in Discussion Group

Wikify editor is a simple editor for wiki-style mark-up. It was written by MDPI for Sciforum in 2014. The rendering of the mark-up is based on Wiky.php with some tweaks. Rendering of mathematical equations is done with MathJax. Please send us a message for support or for reporting bugs.

Close menu

Please declare any conflicts of interest you may have with this paper, financial or otherwise.

I do not have a conflict of interest

I would like to declare a conflict of interest

Display my name on the website

Captcha

Renew

I accept the following conditions:

Comments must follow the standards of professional discourse and should focus on the scientific content of the article. Insulting or offensive language, personal attacks and off-topic remarks will not be permitted. Comments must be written in English. Preprints reserves the right to remove comments without notice. Readers who post comments are obliged to declare any competing interests, financial or otherwise.

* All users must log in before leaving a comment

Notify me about updates to this article or when a peer-reviewed version is published.

ACE Inhibitors and AT1R Blockers for COVID-2019: Friends or Foes ?

Abstract

Keywords

Subject

Comments (1)